chylous leakage

  • 文章类型: Systematic Review
    背景:乳糜漏是食管切除术后的一种罕见并发症;然而,会导致死亡.我们旨在系统评估可能导致食管切除术后乳糜漏增加的因素。
    方法:三个数据库(PubMed、Embase,和Cochrane图书馆)进行了系统搜索,以了解所有研究食管切除术后乳糜漏的发生。
    结果:共确定了32项研究,包括26项随机对照试验和3项队列和病例对照研究,each.乳糜渗漏的总发生率为4.7%(278/5,971例)。术前分析,术中,和术后因素显示,大部分定性分析结果并没有明显增加乳糜漏的发生率。在一些定量分析中,胸导管包块结扎组乳糜渗漏率显著低于保守治疗组(相对危险度[RR]=0.33;95%可信区间[CI],0.13-0.83;I2=0.0%;P=0.327)。与空肠造口术相比,直接经口喂养可显着减少乳糜渗漏(RR=0.06;95%CI0.01-0.33;I2=0.0%;P=0.335)。然而,术前吸气肌训练(RR=1.66;95%CI,0.21-12.33;I2=55.5%;P=0.134),术前放化疗(RR=0.99;95%CI,0.55-1.80;I2=0.0%;P=0.943),和机器人辅助(RR=1.62;95%CI,0.92-2.86;I2=0.0%;P=0.814)并没有显著降低乳糜渗漏的发生率。
    结论:结扎胸导管并直接经口喂养可降低食管癌患者术后乳糜漏的发生率。其他影响因素仍不清楚,需要在进一步的高质量研究中进行验证。
    BACKGROUND: Chylous leakage is a rare complication following esophagectomy; however, it can lead to mortality. We aimed to systematically evaluate the factors that may lead to increased chylous leakage after esophagectomy.
    METHODS: Three databases (PubMed, Embase, and Cochrane Library) were systematically searched for all studies investigating the occurrence of chylous leakage after esophagectomy.
    RESULTS: A total of 32 studies were identified, including 26 randomized controlled trials and 3 cohort and case-control studies, each. The overall incidence of chylous leakage was 4.7% (278/5,971 cases). Analysis of preoperative, intraoperative, and postoperative factors showed that most of the qualitative analysis results did not significantly increase the incidence of chylous leakage. In some quantitative analyses, the chylous leakage rate was significantly lower in the thoracic duct mass ligation group than in the conservative treatment group (relative risk [RR] = 0.33; 95% confidence interval [CI], 0.13-0.83; I2 = 0.0%; P = 0.327). Direct oral feeding significantly reduced chylous leakage compared with jejunostomy (RR = 0.06; 95% CI 0.01-0.33; I2 = 0.0%; P = 0.335). However, preoperative inspiratory muscle training (RR = 1.66; 95% CI, 0.21-12.33; I2 = 55.5%; P = 0.134), preoperative chemoradiotherapy (RR = 0.99; 95% CI, 0.55-1.80; I2 = 0.0%; P = 0.943), and robotic assistance (RR = 1.62; 95% CI, 0.92-2.86; I2 = 0.0%; P = 0.814) did not significantly reduce the incidence of chylous leakage.
    CONCLUSIONS: Ligation of the thoracic duct and direct oral feeding can reduce the incidence of chylous leakage after esophagectomy in patients with esophageal cancer. Other contributing factors remain unclear and require validation in further high-quality studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • DOI:
    文章类型: Journal Article
    乳糜瘘(CF)是罕见的手术并发症,没有标准的治疗方法。这项研究提出了在10年内发展CF的患者的治疗方式。在观察期间,29例患者出现CF,其中16人是妇女。平均年龄为55.76±13.48。淋巴管损伤多见于腹部(58.6%),最常见的原因是肾切除术(20.7%)。在所有病例中,有82.7%的患者因恶性肿瘤而进行了淋巴清扫。术后3.78±3.94天(范围:1-19天)开始发生乳糜渗漏。禁食,全胃肠外营养(TPN),对所有患者应用生长抑素治疗,75.8%的瘘管通过药物治疗完全解决。7例患者进行了淋巴管结扎术。其中一个未成功,并接受了胸淋巴漏腔的经皮栓塞。所有瘘管在18.18±10.4天内解决。胸瘘的解决时间和住院时间显着增加(分别为p=0.017;p=0.003)。此外,恶性病例的消退时间(32.40±28.72vs16.27±11.25,p=0.036)和住院时间(分别为35.0±29.74vs16.25±14.05p=0.002)。没有乳糜胸,乳糜腹水,随访20.55±22.88个月或复发。空腹治疗CF,TPN,和生长抑素类似物是有效的。当保守治疗失败时,可以考虑其他干预措施,例如有或没有纤维蛋白胶的手术结扎和介入放射学治疗。
    Chylous fistulas (CF) are rare surgical complications and there is no standard treatment. This study presents the treatment modalities performed on patients who developed CF over a 10-year period. During the observation period, CF developed in 29 patients, 16 of whom were women. The mean age was 55.76± 13.48. Lymphatic duct injury was mostly seen in the abdomen (58.6%) and the most common reason was nephrectomy (20.7%). Extended lymphatic dissection due to malignancy was performed in 82.7% of all cases. Chylous leakage started postoperatively on 3.78±3.94 days (range: 1-19 days). Fasting, total parenteral nutrition (TPN), and somatostatin treatment were applied to all patients, and 75.8% of the fistulas were resolved completely with medical treatment. Surgical ligation of the lymphatic canal was performed in 7 patients. One was not successful and underwent percutaneous embolization of the thoracic lymphatic leakage cavity. All fistulas were resolved in 18.18±10.4 days. The resolution time and hospital stay were significantly higher in thoracic fistulas (p=0.017; p=0.003, respectively). In addition, malignant cases had longer resolution time (32.40±28.72 vs 16.27±11.25, p=0.036) and hospital stay (35.0±29.74 vs 16.25±14.05p= 0.002 respectively) than non-malignant. There was no chylothorax, chylous ascites, or recurrence at 20.55±22.88 months follow-up. Treatment of CF with fasting, TPN, and somatostatin analogs are effective. Other interventions such as surgical ligation with or without fibrin glue and interventional radiology treatments may be considered when conservative treatments fail.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    术后乳糜渗漏(CL)是指术后乳糜微粒液的病理性渗漏。这项回顾性研究旨在评估术后CL的统一口服营养管理策略。
    我们回顾性分析了2020年5月至2022年4月在大连医科大学附属第二医院7个科室接受临床营养师咨询的术后发生CL的患者。我们设计了口服营养干预计划,该计划主要标准化了中链甘油三酸酯(MCT)饮食中所含食物的类型和数量。分析疗效的影响因素。最后,二元logistic回归分析观察疗效与潜在预测变量之间的关系,包括术后白蛋白,术后血红蛋白,外科手术,和排水量在咨询。
    63例术后CL患者纳入本分析。在这个数字中,58例患者在没有其他治疗的情况下成功治愈。三名患者的恢复期明显延长,其余2例采用再次手术治疗。在七个手术科室和手术部位(左,对,中位数,和双边)。心脏介入术后CL患者的住院时间(LOS)无明显增长,肝胆,胃肠,还有泌尿外科手术.在妇科(P=0.044)和甲状腺外科(P=0.008)中,有CL的患者的LOS长于无CL的患者。手术后血红蛋白的每增加一个单位将使有效结果的可能性增加8%,差异有统计学意义(P=0.037)。
    在治疗术后CL患者时,我们推荐MCT饮食和EN作为第一选择,而不是禁食,肠外营养(PN),或者奥曲肽.
    UNASSIGNED: Post-operative chylous leakage (CL) is the pathologic leakage of chylomicron fluid after surgery. This retrospective study was performed to evaluate a uniform oral nutrition management strategy on the post-operative CL.
    UNASSIGNED: We retrospectively reviewed patients who developed post-operative CL and received consultation from a clinical nutritionist in seven departments of the Second Affiliated Hospital of Dalian Medical University from May 2020 to April 2022. We designed the oral nutrition intervention program which mainly standardized the type and amount of foods contained in the medium-chain triglyceride (MCT) diet. The influencing factors of curative efficacy were analyzed. Finally, binary logistic regression analysis was conducted to observe the relationship between curative efficacy and potentially predictive variables, including post-operative albumin, post-operative hemoglobin, surgical procedure, and drainage volume at consultation.
    UNASSIGNED: Sixty-three patients with post-operative CL were included in this analysis. Of this number, 58 patients were cured successfully without other treatments. Three patients had a significantly prolonged recovery period, and the remaining two cases were treated by reoperation therapy. The leakage volume at the initiation of enteral intervention had no statistically significant difference in seven surgical departments and surgical sites (left, right, median, and bilateral). The length of stay (LOS) of patients with CL after the intervention was not significantly increased in cardiac, hepatobiliary, gastrointestinal, and urological surgeries. Patients with CL had longer LOS than those without CL in gynecology (P=0.044) and thyroid surgery departments (P=0.008). Each unit increase in post-operative hemoglobin would increase the probability of an effective outcome by 8%, which was statistically significant (P = 0.037).
    UNASSIGNED: In treating patients with post-operative CL, we recommend the MCT diet and EN as the first option, rather than fasting, parenteral nutrition (PN), or octreotide.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    乳糜漏是颈淋巴结清扫术(ND)的一种罕见但严重的术后并发症。大多数乳糜渗漏通过引流或胸导管结扎成功治疗。但是决议有时会延长。OK432硬化疗法用于治疗各种难治性头颈部囊性疾病。三名患者接受OK432硬化疗法治疗,治疗ND后难治性乳糜漏。病例1涉及一名77岁的男子,在全喉切除术和双侧ND后发生乳糜漏。病例2涉及一名71岁的女性,她接受了甲状腺全切除术,并因甲状腺癌而左ND。病例3涉及一名61岁的女性,她因口咽癌接受了右ND。在所有患者中,注射OK432后乳糜渗漏迅速改善,无任何并发症。我们的结果表明,OK432硬化疗法对ND后难治性乳糜漏患者的疗效。
    Chylous leakage is a rare but serious postoperative complication of neck dissection (ND). Most chylous leakages are successfully treated either by drainage or ligation of the thoracic duct, but the resolution is occasionally prolonged. OK432 sclerotherapy is used to treat various refractory cystic diseases of the head and neck. Three patients were treated with OK432 sclerotherapy for refractory chylous leakage following ND. Case 1 involved a 77-year-old man with chylous leakage after a total laryngectomy and bilateral ND. Case 2 involved a 71-year-old woman who underwent total thyroidectomy and left ND for thyroid cancer. Case 3 involved a 61-year-old woman who underwent right ND for oropharyngeal cancer. In all patients, chylous leakage rapidly improved after OK432 injection without any complications. Our results suggest the efficacy of OK432 sclerotherapy in patients with refractory chylous leakage after ND.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    霍纳综合征(HS),由3-神经元眼交感神经通路(ONP)的病变引起,包括三合会:眼睑下垂,瞳孔缩小和无汗症(同侧ONP损伤)。甲状腺相关HS代表甲状腺结节/甲状腺肿/癌症HS(T-HS)下方的异常实体,和甲状腺切除术后HS(Tx-HS)。我们的目标是概述Tx-HS。这是一个叙述性的审查。我们修订了PubMed出版,全长,英语论文从开始到2022年11月。此外,我们介绍了甲状腺切除术后淋巴囊肿/乳糜漏(Tx-L)的数据,并引入了同时患有Tx-HS和Tx-L的新儿科病例。Tx-HS:统计证据的水平与孤立病例报告不同,分析甲状腺切除术后并发症大小组的研究报告HS中最罕见的副作用(与低钙血症相反),或由于各种疾病而导致的不同系列的HS患者,包括T-HS/Tx-HS。Tx-HS与良性或恶性甲状腺疾病有关,不管手术的类型。T-HS的术前比率为0.14%;Tx-HS的术后比率在0.03%至5%之间(大多数,确定了0.2%);描述了内窥镜而不是开放式手术的可能较高的风险。HS表格不完整,和儿科发病被确定,也是;最早的鉴定是在干预后2小时后。在大多数情况下,在前2-6个月至一年内,预期会逐渐缓解。管理大多是保守的;一些使用糖皮质激素和神经营养剂。一个主要的陷阱是一个额外的因素,如手术后收集引起的局部压迫(血肿,囊肿,瘘管,Tx-L)及其校正可改善结果。预后可能取决于颈交感神经链(CSC)病变的严重程度:间接,局部压迫性肿块造成的轻度损伤,CSC的术中损伤,如缺血和牵开器对CSC的拉伸与HS恢复有关,而CSC部分是不可逆的。其他医源性因素是:甲状旁腺的手术内操作,甲状腺微波/射频消融,和高强度聚焦超声,并经皮给甲状腺结节注射乙醇.Tx-L,很少报告(主要是0.5%,除了一项研究中8.3%的比例),与扩展手术相关,尤其是外侧/中央颈夹层,和先天性异常淋巴管的存在;是的,还,在内窥镜手术和胸乳入路后描述;它在手术后几天内开始。通常低脂饮食(甚至空腹和父母营养)和引流管是有用的(作为保守管理的一部分);一些使用奥曲肽,像高渗葡萄糖这样的局部密封溶液,Viscum专辑摘录,2-氰基丙烯酸正丁酯。在严重的情况下,由于淋巴和乳糜胸的风险,需要重新干预。早期识别Tx-HS和Tx-L可改善结果。一些医源性并发症是不可避免的,仍然需要多因素预测模型,还考虑到标准化的操作程序,熟练的手术内操作,并对患者进行术后密切随访,尤其是在现代时期,甲状腺手术取得了巨大进展,患者可以提前出院。
    Horner’s syndrome (HS), caused by lesions of the 3-neuron oculosympathetic nerve pathway (ONP), includes the triad: blepharoptosis, miosis and anhidrosis (ipsilateral with ONP damage). Thyroid−related HS represents an unusual entity underling thyroid nodules/goiter/cancer−HS (T-HS), and post-thyroidectomy HS (Tx-HS). We aim to overview Tx-HS. This is a narrative review. We revised PubMed published, full-length, English papers from inception to November 2022. Additionally, we introduced data on post-thyroidectomy lymphocele/chylous leakage (Tx-L), and introduced a new pediatric case with both Tx-HS and Tx-L. Tx-HS: the level of statistical evidence varies from isolated case reports, studies analyzing the large panel of post-thyroidectomy complications reporting HS among the rarest side effects (as opposite to hypocalcemia), or different series of patients with HS due to various disorders, including T-HS/Tx-HS. Tx-HS is related to benign or malignant thyroid conditions, regardless the type of surgery. A pre-operatory rate of T-HS of 0.14%; a post-operatory rate of Tx-HS between 0.03% and 5% (mostly, 0.2%) are identified; a possible higher risk on endoscopic rather than open procedure is described. Incomplete HS forms, and pediatric onset are identified, too; the earliest identification is after 2 h since intervention. A progressive remission is expected in most cases within the first 2−6 months to one year. The management is mostly conservative; some used glucocorticoids and neurotrophic agents. One major pitfall is an additional contributor factor like a local compression due to post-operatory collections (hematoma, cysts, fistula, Tx-L) and their correction improves the outcome. The prognostic probably depends on the severity of cervical sympathetic chain (CSC) lesions: indirect, mild injury due to local compressive masses, intra-operatory damage of CSC like ischemia and stretching of CSC by the retractor associate HS recovery, while CSC section is irreversible. Other iatrogenic contributors to HS are: intra-operatory manipulation of parathyroid glands, thyroid microwave/radiofrequency ablation, and high-intensity focused ultrasound, and percutaneous ethanol injection into thyroid nodules. Tx-L, rarely reported (mostly <0.5%, except for a ratio of 8.3% in one study), correlates with extended surgery, especially lateral/central neck dissection, and the presence of congenitally—aberrant lymphatic duct; it is, also, described after endoscopic procedures and chest-breast approach; it starts within days after surgery. Typically low-fat diet (even fasting and parental nutrition) and tube drainage are useful (as part of conservative management); some used octreotide, local sealing solutions like hypertonic glucose, Viscum album extract, n-Butyl-2-cyanoacrylate. Re-intervention is required in severe cases due to the risk of lymphorrhoea and chylothorax. Early identification of Tx-HS and Tx-L improves the outcome. Some iatrogenic complications are inevitable and a multifactorial model of prediction is still required, also taking into consideration standardized operatory procedures, skillful intra-operatory manipulation, and close post-operatory follow-up of the patients, especially during modern era when thyroid surgery registered a massive progress allowing an early discharge of the patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    背景:腹腔镜胆囊切除术是胆结石疾病的常见手术选择,创伤小,恢复快。腹水是腹腔镜胆囊切除术后相对罕见的并发症,在术前肝功能异常的患者中更常见。然而,无基础肝病的患者在腹腔镜胆囊切除术后出现顽固性腹水的情况很少见.我们报告了一例腹腔镜胆囊切除术后由淋巴损伤引起的大量腹水。
    方法:一名63岁女性因胆囊结石行腹腔镜胆囊切除术后第12天主诉腹部不适和腹胀。随后,患者出现自发性细菌性腹膜炎和尿量减少。腹部计算机断层扫描(CT)发现腹部积液。患者接受腹腔穿刺术,微浑浊的黄色腹水平均每天1500-2000毫升。腹水的实验室分析结果显示:血清-腹水白蛋白梯度(SAAG),11-12g/L;白蛋白,11-14g/L;甘油三酯,0.91mmol/L利尿剂治疗后,重复大量穿刺补充白蛋白,使用抗生素和肾血管舒张药物,病人的症状没有缓解。淋巴闪烁显像在腹腔中发现了少量放射性填充物。患者最终接受了手术,并检测并结扎了淋巴漏。腹水消失,患者恢复良好。
    结论:对于乳糜性腹水的非典型特征患者,淋巴扫描可以帮助定位和定性诊断。保守治疗失败时可考虑手术治疗。
    BACKGROUND: Laparoscopic cholecystectomy is a common surgical option for gallstone disease with minimal trauma and rapid recovery. Ascites is a relatively uncommon complication after laparoscopic cholecystectomy and is more frequently observed in patients with preoperative abnormal liver function. However, patients without underlying liver disease develop refractory ascites after laparoscopic cholecystectomy are rare. We report a case of massive ascites caused by lymphatic injury after laparoscopic cholecystectomy.
    METHODS: A 63-year-old woman complained of abdominal discomfort and distension at the twelfth day after a laparoscopic cholecystectomy for gallbladder stones. Subsequently, the patient developed spontaneous bacterial peritonitis and a decreased output of urine. Abdominal computed tomography (CT) identified abdominal effusion. The patient received abdominocentesis and the volume of slightly turbid yellow ascites averaged 1500-2000 ml per day. The results of laboratory analysis of ascitic fluid showed the following: serum-ascites albumin-gradient (SAAG), 11-12 g/L; albumin, 11-14 g/L; triglycerides, 0.91 mmol/L. After the diuretic therapy, repeated large-volume paracentesis with albumin supplementation, administration of antibiotics and renal vasodilating medications, the patient\'s symptoms did not relieve. Lymphoscintigraphy found a small amount of radioactive filling in the abdominal cavity. The patient finally received surgery with detection and ligation of the lymphatic leak. The ascites disappeared and the patient recovered well.
    CONCLUSIONS: For patients with atypical characteristics of chylous ascites, lymphoscintigraphy could help to localize and qualify the diagnosis. Surgical treatment could be considered when conservative treatment fails.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    滑膜肉瘤通常出现在下肢并转移到肺部;然而,可能会出现不寻常的复发模式。对于复发性滑膜肉瘤至近端胰周淋巴结的患者,胰十二指肠切除术或Whipple手术是治愈的最佳选择。滑膜肉瘤的淋巴结转移非常罕见,指导使用Whipple手术进行转移性滑膜肉瘤根治性切除的数据更加稀疏。在这份报告中,我们描述了一个转移性滑膜肉瘤患者的近端胰周淋巴结和胰十二指肠切除术的处理。
    Synovial sarcoma usually presents in the lower extremities and metastasizes to the lungs; however, unusual patterns of recurrence can occur. For patients with recurrent synovial sarcoma to a proximal peripancreatic lymph node, a pancreaticoduodenectomy or Whipple procedure is the best option for a cure. Lymph node metastasis from synovial sarcoma is exceptionally rare, and data guiding the use of the Whipple procedure for curative resection of metastatic synovial sarcoma are even more sparse. In this report, we describe the management of a patient with metastatic synovial sarcoma to a proximal peripancreatic lymph node with a pancreaticoduodenectomy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    乳糜漏是乳腺和腋窝手术的罕见并发症。我们介绍了一例保乳手术和腋窝淋巴结清扫术后乳房内乳糜渗漏的病例。乳房中的大多数乳糜渗漏均采用旨在减少淋巴液产生和流出的保守措施进行管理。在保守治疗失败和高输出乳糜渗漏的情况下,需要手术干预。据我们所知,这是首例成功通过手术治疗的保乳手术后乳房内部发生chyles渗漏的病例报告。
    Chylous leakage is a rare complication of breast and axillary surgery. We present a case of chylous leakage inside the breast following breast-conserving surgery and axillary lymph node dissection. The majority of chylous leakages in the breast are managed with conservative measures aimed at reducing lymphatic fluid production and outflow. Surgical intervention is required in cases of conservative treatment failure and high output chylous leakage. To the best of our knowledge, this is the first case report of chyles leaks inside the breast following breast-conserving surgery that was successfully treated surgically.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    描述三个机构的上尿路尿路上皮癌患者腹膜后腹腔镜根治性肾输尿管切除术后腹膜后淋巴结清扫术的详细围手术期并发症及其处理。
    对位于骨盆和/或输尿管上部或中部的上尿路上皮癌患者进行腹膜后淋巴结清扫。其模板包括肾门和主动脉旁淋巴结(左侧)和肾门,paracaval,后腔静脉,和主动脉腔内淋巴结(右侧)。全部切除淋巴结和肾脏。主要终点是术后并发症发生率,次要终点是术中发现和乳糜渗漏管理。使用倾向评分逻辑回归技术检查腹膜后淋巴结清扫与术后并发症的关系。
    88例(31%)和195例(69%)患者接受但未接受腹膜后淋巴结清扫术,分别。在整个队列中,术后并发症和其他围手术期发现没有显着差异,除了延长的操作时间。在倾向评分分析中,腹膜后淋巴结清扫与总并发症和严重并发症无统计学意义。即使在腹膜后淋巴结清扫术患者中很常见(14/88(16%)),术后乳糜漏也可以保守治疗。在腹膜后淋巴结清扫术中精心完全夹住淋巴管的患者,乳糜漏的发生率显着降低(5.3%vs24%;P=0.017)。
    腹膜后淋巴结清扫术与腹腔镜肾癌根治术与术后并发症无相关性。然而,腹膜后淋巴结清扫后经常观察到乳糜漏,高度需要小心处理。建议在腹膜后淋巴结清扫术中使用夹子,以最大程度地减少乳糜渗漏的风险。
    To describe the detailed perioperative complications and their management after retroperitoneal lymph node dissection with retroperitoneal laparoscopic radical nephroureterectomy for patients with upper tract urothelial carcinoma at three institutions.
    Retroperitoneal lymph node dissection was performed on patients with upper tract urothelial carcinoma located at the pelvis and/or upper or middle ureter, and its template included the renal hilar and para-aortic lymph nodes (left side) and the renal hilar, paracaval, retrocaval, and intra-aortocaval lymph nodes (right side). The lymph nodes and kidneys were removed en bloc. The primary endpoint was postoperative complication rates, and the secondary endpoints were intraoperative findings and chylous leakage management. The associations of retroperitoneal lymph node dissection with postoperative complications were examined using logistic regression with propensity score techniques.
    Eighty-eight (31%) and 195 (69%) patients underwent and did not undergo retroperitoneal lymph node dissection, respectively. There was no significant difference in postoperative complications and other perioperative findings in the entire cohort, except for prolonged operation time. Retroperitoneal lymph node dissection was not statistically significantly associated with total and serious complications in propensity score analyses. Postoperative chylous leakage could be conservatively managed even though it is common in patients with retroperitoneal lymph node dissection (14/88 (16%)). The incidence of chylous leakage was significantly lower in patients whose lymphatic vessels were meticulously clipped completely during retroperitoneal lymph node dissection (5.3% vs 24%; P = 0.017).
    There was no association between retroperitoneal lymph node dissection with laparoscopic radical nephroureterectomy and postoperative complications. However, chylous leakage is often observed after retroperitoneal lymph node dissection and careful management is highly required. The use of clips during retroperitoneal lymph node dissection is recommended to minimize chylous leakage risk.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号